An Incisive, In-depth Analysis on the Digital Pathology Market
This study offers a comprehensive, 360 degree analysis on the Digital Pathology market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Digital Pathology market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Advent of Personalized Medicines in Cancer Treatment
Personalized medicine is a medical model used for the treatment and prevention of diseases on individual patients, based on predicted response. In personalized medicine, each patient is individually treated based on his/her genetic makeup. Personalized medicine research is gaining popularity in the cancer research industry, owing to its promising benefits in cancer treatment. However, the limited data sharing of test results and lack of integrated diagnostic solutions are reducing the efficacy of proposed outcomes of test samples. These new challenges in the development of personalized medicine have created a need for faster and reliable diagnostic procedures to make quick decisions based on a broader view of the disease. Hence, pathologists are keen to adopt digital pathology to facilitate the growth of personalized medicine research.
Reforming Healthcare IT Spending Structure
Increasing spending on building more advanced IT infrastructure in the healthcare sector is expected to represent new avenues for growth of the digital pathology market. The ability of digital pathology solutions in providing cloud-based pathology services would eventually enable remote data sharing in the form of digital outcomes. The overall spending on clinical healthcare IT is expected to increase to 20.9 Bn by 2020. Manufacturers of digital pathology systems in developed countries are extensively targeting cloud-based platforms for data analysis and interpretation in the healthcare sector. This would result in prominent growth opportunities for the digital pathology market in the region and is expected to fuel adoption in clinical and medical verticals across developed regions.
Outsourced Research and Development Activities
The biopharmaceutical industry has experienced substantial numbers of patent expiration in the last decade. This has increased the demand for biosimilar research and developments, especially for cancer treatment. Moreover, growth in the number of clinical trials conducted for the development of novel biologics for rare disease are likely to create extensive demand for cost-effective image analysis solution. Pharmaceutical companies are allocating tasks of biosimilar development to Contract Research Organizations (CROs), in-vitro diagnostics (IVD) companies, clinical laboratories, regulatory consultants, and Contract Manufacturing Organizations (CMOs), and these companies are improvising to provide more cost-effective solutions to clients and, in turn, leading to an increase in the adoption of digital pathology technologies.
Commercialization of Multipurpose Instruments with Cloud-Enabled Technologies
The digital pathology market has witnessed a promising change in terms of product innovation in the last decade. One of the key reasons behind this is the scope of cloud integration with pathology outcomes, which has reduced the challenges of data sharing between pathology laboratories. This potential scope of digital pathology with respect to cloud integration has highly benefited the cancer research industry and represents promising potential for other therapies as well. Innovation in terms of product capabilities and other modalities is another factor expected to drive the growth of the digital pathology market
Novel Product Development to Fuel Commercial Growth
The digital pathology industry is evolving at a rapid pace and is expected to favor companies that have primary focus on product development during the forecast period. Manufacturers engaged in the development of novel DP solutions are focusing on introducing highly-advanced and more user-friendly instruments to meet the varying needs of consumers. Majority of the major players in this industry are focusing on the commercialization of cost-effective digital pathology systems in order to exhibit their core competencies in small scale pathologies. Moreover, these companies are also focusing on integrating with cloud service providers to provide total services to consumers.
The competition section of the digital pathology market features the profiles of key players operating in the industry based on their market shares, product offerings, differential channel strategies, marketing initiatives, product reach and company dashboard. Some of the key players featured in the report include Perkin Elmer, Inc., Sectra AB, Definiens AG, 3D-Histech Ltd., Ventana Medical Systems, , Koninklijke Philips N.V, GE Healthcare, Olympus Corporation, Inspirata Co., , Inc., Leica Biosystems, Digipath Co., ZEISS, Yokogawa Electronic Corporation Hamamatsu Photonics, K.K. and Quorum Technologies Inc.
Manufacturers are focusing on the integration of digital pathology with cloud platform and are collaborating with cloud service providers to provide overall data sharing and scanning services to clients. For instance, on Sept 2018, Philips IntelliSite Pathology Solution collaborated with Oxford University Hospitals NHS Foundation Trust to enhance patient care by advancing pathology services. This collaboration will significantly reduce the operational cost associated with pathology services, slide transportation time, and also enable quicker access to physicians.
Companies are focusing on mergers and acquisitions to introduce novel digital pathology instruments so as to cater to the end users operating in the healthcare sector. These companies are focusing on the acquisition of startups that have existing products and products with novel specifications in the pipeline.
Digital pathology is a dynamic, image-based environment that enables the acquisition and interpretation of pathology information. Digital pathology is also known as “Virtual Microscopy”. Digitized glass slides are analyzed under a scanner containing highly specialized cameras comprising advanced optical sensors, microscopes with lenses, robotics to load and move glass slides and a light source, i.e. bright field and fluorescent. Depending upon the light source, these scanners are classified into three categories: bright field scanner, fluorescent scanner and combination of bright field and fluorescent scanner.
About the Report
FMI conducted a research study of the digital pathology market for the forecast period (2015–2025). The report offers a comprehensive evaluation of the business opportunities prevailing in the digital pathology market along with insights on the consumer adoption, industry life cycle and competition strategies. The report also covers comprehensive attributes of cloud services, commercial progress of digital pathology, and installed base scenario of whole slide imaging systems, pricing analysis, company penetration and market competition. The report elaborates on the macro factors influencing the digital pathology market.
The report offers a comprehensive taxonomy of the digital pathology market based on product type, end user, pathology screening services and region. Based on imaging systems, the digital pathology market has been segmented into bright field scanners & fluorescence scanners. The software solutions and services segment of the report covers the regional market value of image analysis platforms & digital pathology information systems. The end use segments of the report cover hospitals, diagnostic laboratories and research centers. The report also covers the demand-side aspect of digital pathology screening services for various applications. On the basis of region, the digital pathology market has been segmented into North America, Eastern Europe, Western Europe, Latin America, Asia Pacific Excluding Japan, Japan, Middle East and Africa.
Additional Questions Answered
Some of the additional questions addressed in the digital pathology market report include,
- What is the role of regulatory authorities and software service providers in the market?
- What is the revenue potential of digital pathology across cancer research and diagnostic applications?
- How the digital pathology market is expected to gain momentum in Asia?
- Who are the key competitors and what are their portfolios in the digital pathology market?
- What is the price point for digital pathology manufacturers in developed countries?
FMI has analyzed the market size of the digital pathology market by utilizing a triangulation methodology, in which we have tracked the revenue of key players operating in this segment. We have followed an installed base approach, considering the different set ups of digital pathology instruments (whole slide scanners), the average lifespan of the device, actual replacement and new sales to arrive at the region-wise volume units sold globally. Software and services related to these instruments are tracked based on the usage pattern of these products in a set up. Regional weighted average selling price will be considered to calculate the market size and forecast trends. However, services (maintenance cost and installation cost) costs are collected from the annual contracts of manufacturers or distributors and bills of materials. Primary research was conducted at each node to understand the usage pattern, adoption and historic trends from key opinion leaders, senior lab technicians, lab managers and procurement mangers of diagnostics laboratories, hospitals, and research institutes. These estimates were further validated with industry experts such as manufacturers, distributors and suppliers. Extensive secondary research was carried out to understand the collective information on the number of laboratories, hospitals, research centers in the end use segments by regions, average price and trends and recent developments.
A recent market study published by FMI titled, “Digital Pathology Market: Global Industry Analysis & Opportunity Assessment 2015-2025,” comprises a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the digital pathology market, the growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the digital pathology market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the digital pathology market in the upcoming years. The report provides detailed information about the current and future growth prospects of the digital pathology market in the most comprehensive way for the better understanding of readers.
Chapter 1 – Executive Summary
The report commences with an executive summary of the digital pathology market report, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the digital pathology market.
Chapters 2 & 3 – Research Methodology
The chapters cover an overview of the research methodology followed to estimate regional level market value and volume of the digital pathology market. The chapters also highlight the list of assumptions and acronyms used in the report. They will help readers understand the research methodology followed to obtain various conclusions, important qualitative information and quantitative information regarding the digital pathology market.
Chapter 4 – Market Overview
Readers can find detailed taxonomy and the definition of the digital pathology market in this chapter, which help readers understand the basic information about the digital pathology market. The chapter covers global market value and volume forecast from 2015 to 2025 along with the regional level pricing analysis scenario.
Chapter 5 – Market Dynamics
Readers can find comprehensive information regarding the key market drivers & restraints along with recent illustrations of the digital pathology market. Readers will gain insights on the regulatory landscape, primary research outlook, installed base scenario and technology trends associated with the digital pathology market. The chapter also highlights regional level pricing analysis, product life cycle and the consumer adoption process of digital pathology solutions in various regions.
Chapter 6 – Global Digital Pathology Market Analysis & Opportunity Assessment by Product Type, 2015–2025
Based on the product type, the digital pathology market has been segmented into dialysis scanners and services. In this chapter, readers can find information about the key trends and developments in the digital pathology market and market attractive analysis based on the type of slide scanner used along with various associated services, among other product types in each region.
Chapter 7 – Global Digital Pathology Market Analysis & Opportunity Assessment by End User, 2015–2025
Based on the end user, the digital pathology market has been segmented into hospitals, diagnostic laboratories and research centers. In this chapter, readers can find information about the key trends and developments in the digital pathology market and market attractive analysis on the basis of end user.
Chapter 8 – Global Digital Pathology Market Analysis & Opportunity Assessment by Pathology Screening Services, 2015–2025
In this chapter, the digital pathology market has been categorized on the basis of various applications including chemical pathology, hematology, histopathology and medial microbiology. In this chapter, readers can find information about the digital pathology service market along with key trends and developments and market attractive analysis on the basis of application.
Chapter 9 – Global Digital Pathology Market Analysis & Opportunity Assessment by Region, 2015–2025
This chapter explains how the digital pathology market will grow across various geographic regions such as North America, Asia-Pacific Excluding Japan (APEJ), Japan, Western Europe, Latin America, Eastern Europe and the Middle East & Africa (MEA).
Chapter 10 – North America Digital Pathology Market Analysis & Opportunity Assessment, 2015–2025
This chapter includes a detailed analysis of the growth of the North America digital pathology market along with a country-wise assessment including the U.S. and Canada. Readers can also find regional trends on the basis of product type, end user, pathology screening services and country in the North America region.
Chapter 11 – Latin America Digital Pathology Market Analysis & Opportunity Assessment, 2015–2025
Readers can find detailed information about factors such as pricing analysis and market dynamics that are impacting the growth of the Latin America digital pathology market. This chapter also includes the growth prospects of the digital pathology market in leading LATAM countries such as Brazil, Mexico and the rest of the Latin America region.
Chapter 12 – Western Europe Digital Pathology Market Analysis & Opportunity Assessment, 2015–2025
Important growth prospects of the digital pathology market on the basis of product type, end user and pathology screening services in several European countries such as Germany, France, Italy, Spain, the U.K., BENELUX and the rest of Western Europe are included in this chapter.
Chapter 13 – Eastern Europe Digital Pathology Market Analysis & Opportunity Assessment, 2015–2025
Important growth prospects of the digital pathology market on the basis of product type, end user and pathology screening services in several European countries such as Russia, Poland and rest of Eastern Europe are included in this chapter.
Chapter 14 – APEJ Digital Pathology Market Analysis & Opportunity Assessment, 2015–2025
China, India, ASEAN, Australia and New Zealand are the leading countries in the APEJ region and thus, the prime subject of assessment to obtain the growth prospects of the APEJ digital pathology market. Readers can find thorough information about the growth parameters of the APEJ digital pathology market during the period 2015–2025.
Chapter 15 – Japan Digital Pathology Market Analysis & Opportunity Assessment, 2015–2025
In this section, readers can find important factors that can make a huge impact on the growth of the digital pathology market in Japan during the forecast period. This chapter provides the overview of regulations, drivers, restraints, and trends in the Japan digital pathology market.
Chapter 16 – MEA Digital Pathology Market Analysis & Opportunity Assessment, 2015–2025
This chapter provides information on how the digital pathology market will grow in major countries such as GCC Countries and South Africa in the MEA region during the period 2015–2025.
Chapter 17 – Competition Landscape, Company Share and Company Profiles
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the digital pathology market along with detailed information about each company, including company overview, revenue shares, strategic overview and recent company developments. Market players featured in the report include Perkin Elmer Inc., Sectra AB, Definiens AG, 3D-Histech Ltd., Ventana Medical Systems, Koninklijke Philips N.V, GE Healthcare, Olympus Corporation, Inspirata Inc., Leica Biosystems, Digipath Co., ZEISS, Yokogawa Electronic Corporation Hamamatsu Photonics, K.K. and Quorum Technologies Inc.
Digital Pathology Market Reports - Table of Contents
1. Digital Pathology Market - Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology